NMDA receptors: Recent insights and clinical correlations
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Glutamate is the most abundant excitatory neurotransmitter in the CNS. The excitatory effects of glutamate are mediated by ionotropic and metabotropic receptors. The NMDA receptors (NMDARs) are glutamate-gated cation channels that are highly permeable to calcium (Ca2+) and are essential for regulation of synaptogenesis, use-dependent synaptic remodeling, and long-term plastic changes in synaptic strength. Excessive NMDAR activation leads to excitotoxicity, which results in cell loss in a wide range of acute, degenerative, and demyelinating neurologic disorders. NMDAR-mediated synaptic plasticity may contribute to levodopa-induced dyskinesia, drug addiction, and neuropathic pain; impaired NMDAR function may contribute to cognitive impairment in dementia and schizophrenia. Not surprisingly, the NMDARs are a very attractive therapeutic target. A characteristic syndrome resulting from autoantibodies against NMDARs emphasizes the critical role of these receptors in cognition, behavior and motor, respiratory, and autonomic control. Over the past several years, there have been important advances in the understanding of the molecular composition, trafficking, and distribution of these receptors well as the differential effects of NMDAR subtypes on cell survival and plasticity. There have been recent excellent reviews on these subjects.1,–,10 ### Composition. NMDARs are heteromeric complexes composed of 4 subunits derived from 3 related families: NR1, NR2, and NR3.1,–,5 According to the current proposed nomenclature, these subunits are termed GluN1, GluN2, and GluN3, respectively.11 The classic nomenclature will be used in this review. The NR1 is an obligatory subunit that combines with NR2 or NR3 subunits to form a functional receptor. The NR1 subunit gene can be alternatively spliced to produce 8 distinct NR1 isoforms. Separate genes produce 4 types of NR2 (NR2A–D) and 2 types of NR3 (NR3A–B) subunits.12 The typical NMDAR requires consists of 2 NR1 subunits, which bind glycine, and 2 NR2 subunits, which bind glutamate …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents
Florance, N. R., Davis, R. L., Lam, C., Szperka, C., Zhou, L., Ahmad, S., Campen, C. J., Moss, H., Peter, N., Gleichman, A. J., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21756 · Cited by 1,090
NMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury
Arundine, M., & Tymianski, M. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3319-x · Cited by 647
Cited by
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Tuo, Q., Zhang, S., & Lei, P. (2022) · Medicinal Research Reviews · doi:10.1002/med.21817 · Cited by 728
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
“Abnormal NMDAR activity is associated with seizure, ischemic stroke (Choi et al., 1988; Villmann and Becker, 2007), and neurodegenerative disorders (Benarroch, 2011), such as Alzheimer’s (Wenk, 2006), Huntington’s (Fan and Raymond, 2007), and Parkinson’s disease (Bonuccelli and Del Dotto, 2006).”
BackgroundManagement of refractory status epilepticus in adults: still more questions than answers
Rossetti, A. O., & Lowenstein, D. H. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70187-9 · Cited by 341
Zhou, X., Hollern, D., Liao, J., Andrechek, E., & Wang, H. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.82 · Cited by 200
Niesters, M., Khalili-Mahani, N., Martini, C., Aarts, L., van Gerven, J., van Buchem, M. A., Dahan, A., & Rombouts, S. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31826a0db3 · Cited by 147
Metadata
- Authors
- Benarroch, E. E.
- Venue
- Neurology
- Published
- 2011-05-17
- Volume
- 76
- Issue
- 20
- Pages
- 1750-1757
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2000204672
- Cited by
- 90
- References
- 17
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NMDA receptors: Recent insights and clinical correlations. https://app.cochat.ai/papers/10.1212/wnl.0b013e31821b7cc9
- The paper
- Benarroch, E. E. (2011). NMDA receptors: Recent insights and clinical correlations. Neurology. https://doi.org/10.1212/wnl.0b013e31821b7cc9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.